"2007-2010 Global Vaccine Market Outlook" is an extensive market research report that gives an objective analysis on the global vaccine market. It covers both past and current performance of the market, as well as highlights the trends that are expected to impact the future of the market.
The global vaccine market, which was earlier thought as a low margin, low growth industry, is currently attracting the interest of all major pharmaceutical giants. The market is presently witnessing growth rates much faster than the traditional pharmaceutical market; and with many new blockbuster potential vaccines likely to hit the market in future, the growth is only expected to increase.
The biggest factor driving the vaccine market is its potential to prevent deaths due to diseases. Vaccines have eradicated many life-threatening diseases and many more vaccines are in the pipeline, which may serve as future life saviors (particularly those for several types of cancers which are expected to be launched around 2008). However, several challenges still remain, one of the biggest being the wide gap between the developed and the developing world in terms of accessibility and quality of vaccines.
Key Findings
- Growing at the rate of 16.52%, global vaccine market is expected to reach US$ 21.05 Billion by 2010.
- Cancer and addiction vaccines will grow rapidly through 2010.
- At present, pediatric vaccines occupy a higher market share but in future, this segment will loose its share to the adult, therapeutic and influenza vaccine segments.
- The US is the largest market globally for vaccines followed by Europe.
- Flu vaccines have huge demand at present and all major vaccine manufacturers are investing in the segment.
- Vaccines have been found to be more profitable than the generic pharmaceutical drugs but fetch fewer margins than branded drugs.
- The global vaccine market, in its bid to reduce costs and time to market, is likely to drive the global drug discovery CRO market.
Key Issues Analyzed
- Evaluation of past, current and future market trends.
- Discussion on major vaccines and their markets.
- Future forecast of major vaccines.
- Analysis of various challenges and opportunities for the industry.
- Categories of players operating in the market along with their business profiles.
Research Methodology Used
Information Sources: Information has been sourced from various credible sources like books, newspapers, trade journals and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.
Analysis Methods: The analysis methods ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.
Table of Contents
Section 1 Analyst View
Section 2 Research Overview
Section 3 Vaccines - An Introduction
3.1 History
3.2 Vaccine Production Stages
3.2.1 Cultivation
3.2.2 Purification
3.2.3 Quality Control
3.2.4 Packaging
3.3 Vaccine Approval Process
3.3.1 Phase I
3.3.2 Phase II
3.3.3 Phase III
3.3.4 Phase IV
3.4 Regulatory Frameworks & Intellectual Property Rights
3.4.1 Product Equals Process
3.4.2 Regulatory Requirements
3.4.3 Patent Protections
3.5 Types of Vaccine
3.5.1 Live Attenuated Vaccines
3.5.2 Killed Vaccines
3.5.3 Toxoid Vaccines
3.5.4 Component Vaccines
3.5.5 Genetically Engineered Vaccines
3.5.6 DNA Vaccines
Section 4 Market Analysis
4.1 Global Vaccine Market
Section 5 Industry Performance
5.1 Key Geographical Markets
5.1.1 US
5.1.2 Europe
5.1.3 Japan
5.1.4 China
5.1.5 India
5.1.6 Brazil
5.2 Major Vaccine Segments
5.2.1 Basic Pediatrics
5.2.2 Enhanced Pediatrics
5.2.3 Proprietary Pediatrics
5.2.4 Adult/Travel
5.2.5 Therapeutics
5.2.5.1 Cancer Vaccines
5.2.5.2 Addiction Vaccines
5.2.6 Influenza
Section 6 Major Pediatric Vaccines
6.1 Pneumococcal Vaccines
6.2 Polio Vaccines
6.3 Varicella Vaccines
6.4 Meningitis Vaccines
6.5 Rotavirus Vaccines
6.6 DTP Vaccines
6.7 Measles, Mumps & Rubella (MMR) Vaccines
6.8 Tuberculosis Vaccines
Section 7 Major Adult/Travel & Therapeutic Vaccines
7.1 Hepatitis B Vaccines
7.2 Malaria Vaccines
7.3 Japanese Encephalitis Vaccines
7.4 Ebola Vaccines
7.5 Cervical Cancer Vaccines
7.6 Typhoid Vaccines
7.7 West Nile Vaccines
7.8 HIV Vaccines
Section 8 Industry Analysis
8.1 Market Drivers
8.1.1 Diseases Prevention
8.1.2 Higher Margins
8.1.3 Increased Funding from Government & NGOs
8.1.4 Government Regulations
8.1.5 Blockbuster Potential of New Vaccines
8.1.6 Increasing Population in Developing Countries
8.1.7 Disease Awareness
8.2 Opportunities
8.2.1 Contract Research
8.2.2 Influenza Vaccine Segment
8.2.3 India & China - Future Hub for Pediatric Vaccine Manufacturing
8.2.4 Cancer Vaccine Segment
8.2.5 Addiction Vaccine Segment
8.3 Challenges
8.3.1 Huge R&D Cost
8.3.2 Lack of Infrastructure for Trials & Manufactures
8.3.3 Effective Vaccine Design
8.3.4 Vaccine Supply
8.3.5 Immunization Safety
Section 9 Vaccine Market Players
9.1 Major Categories
9.1.1 Vaccine Majors
9.1.2 Vaccine-focused Biotech Companies
9.1.3 Domestic-focused Vaccine Companies
9.2 Key Players
9.2.1 Sanofi-Aventis
9.2.2 GlaxoSmithKline Plc.
9.2.3 Merck & Co., Inc.
9.2.4 Novartis
9.2.5 Wyeth
Figures
Figure 3-1: Vaccines Horizon*, 1960 to 2010
Figure 4-1: Global - Vaccine Market (in Billion US$), 2003-2006E
Figure 4-2: Global - Forecast for Vaccine Market (in Billion US$), 2007-2010
Figure 5-1: Global - Vaccine Market Segmentation by Region (%), 2005
Figure 5-2: Global - Sales Split of Major Vaccine Player by Region (%), 2004
Figure 5-3: US - Vaccine Market (in Billion US$), 2003, 2006E, 2008E & 2013E
Figure 5-4: US - Pediatric Vaccine Market (in Billion US$), 2003, 2006E, 2008E & 2013E
Figure 5-5: US - Hepatitis Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
Figure 5-6: US - Biodefense Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
Figure 5-7: US - Influenza Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
Figure 5-8: US - Travel Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
Figure 5-9: US - Developmental Vaccine Market (in Million US$), 2008E & 2013E
Figure 5-10: Europe - Vaccine Market (in Billion US$), 2005, 2006E, 2008E & 2012E
Figure 5-11: Japan - Influenza Vaccine Production (in Million Units), 2004-05, 2005-06 & 2006-07E
Figure 5-12: China - Vaccine Market (in Billion RMB) 2004-2006E
Figure 5-13: China - Forecast for Vaccine Market (in Billion RMB) 2007-2010
Figure 5-14: India - Vaccine Market (in Million US$) 2004-05 to 2008-09E
Figure 5-15: India - Share of Domestic Consumption & Exports in Vaccine Market (%), 2005-2006
Figure 5-16: India - Share of Public & Private Sectors in Vaccine Market (%), Nov 2006
Figure 5-17: India - Top 6 Selling Drugs in Vaccine Market (in Rs Crore), 2005-2006
Figure 5-18: Brazil - Vaccine Market (in Million BRL), 2000, 2004, 2006E & 2008E
Figure 5-19: Brazil - Share of Public & Private Sectors in Vaccine Market (%), 2000
Figure 5-20: Global - Vaccine Market by Segment (in Billion US$), 2005, 2006E & 2010E
Figure 5-21: Global - Share of Vaccine Market by Segment (%), 2005, 2006E & 2010E
Figure 5-22: Global - Basic Pediatrics Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-23: Global - Forecast for Basic Pediatrics Vaccine Market (in Billion US$), 2007-2010
Figure 5-24: Global - Enhanced Pediatrics Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-25: Global - Forecast for Enhanced Pediatrics Vaccine Market (in Billion US$), 2007-2010
Figure 5-26: Global - Proprietary Pediatrics Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-27: Global - Forecast for Proprietary Pediatrics Vaccine Market (in Billion US$), 2007-2010
Figure 5-28: Global - Adult/Travel Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-29: Global - Forecast for Adult/Travel Vaccine Market (in Billion US$), 2007-2010
Figure 5-30: Global - Therapeutics Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-31: Global - Forecast for Therapeutics Vaccine Market (in Billion US$), 2007-2010
Figure 5-32: Global - Cancer Vaccine Market (in Billion US$), 2005, 2008E & 2010E
Figure 5-33: Global - Addiction Vaccine Market (in Million US$), 2008E & 2010E
Figure 5-34: Global - Influenza Vaccine Market (in Billion US$), 2005 & 2006E
Figure 5-35: Global - Share of Influenza Vaccine Production by Manufacturer (%), 2006
Figure 5-36: Global - Forecast for Influenza Vaccine Market (in Billion US$), 2007-2010
Figure 6-1: Global - Pneumococcal Vaccine Market (in Billion US$), 2006 & 2010E
Figure 6-2: Global - Number of Polio Incidences, 2004-2006
Figure 6-3: Global - Countries with Maximum Number of Polio Incidences, 2006
Figure 6-4: Global - Polio Vaccine Market (in Million US$), 2004 & 2011E
Figure 6-5: Global - Inactivated Polio Vaccine Doses (in Million), 2006 & 2011F
Figure 6-6: Global - Meningitis Vaccine Market (in Billion US$), 2004 & 2010E
Figure 6-7: Global - Forecast for Rotavirus Vaccine Market (in Billion US$), 2010
Figure 6-8: Global - Forecast for Rotavirus Vaccine Market Segmentation by Region (%), 2010
Figure 6-9: Global - Number of Diphtheria Incidences by Region, 2006
Figure 6-10: Global - Number of Pertussis Incidences by Region, 2006
Figure 6-11: Global - Number of nTetanus Incidences by Region, 2006
Figure 6-12: Global - Number of tTetanus Incidences by Region, 2006
Figure 6-13: Global - Share of DTP Combos Market by Player (%), 2004
Figure 6-14: Global - Number of Measles Incidences by Region, 2006
Figure 6-15: Global - Number of Mumps Incidences by Region, 2006
Figure 6-16: Global - Number of Rubella Incidences by Region, 2006
Figure 6-17: Global - Number of Tuberculosis Incidences (in Thousand), 2005
Figure 7-1: Global - Hepatitis B Surface Antigen Prevalence (%), 2005
Figure 7-2: Global - Hepatitis B Vaccine Market (in Million US$), 1999, 2005, 2006 & 2011F
Figure 8-1: Global - Profit Margins of Vaccines, Generics & Branded Drugs (%), 2007E
Figure 8-2: Global - Sources of Financing for Vaccine Market (%), 2001
Figure 8-3: Global - Prevnar Sales (in Million US$), 2003-2006
Figure 8-4: US - Drug Discovery Contract Research Organization Market (in Billion US$), 2006E & 2013E
Figure 8-5: Global - Dose Consumption & Revenue by Income of Region (%), 2005
Figure 9-1: Global - Share of Vaccine Market by Player (%), 2005
Tables
Table 5-1: China - Vaccines Classification
Table 5-2: China - Pediatric Vaccine Requirement (in Million Doses)
Table 5-3: Brazil - Public & Private Sectors Vaccine Market (in Million BRL), 2000
Table 7-1: Global - Number of HIV/AIDS Patients (in Million), 2006
Table 8-1: Global - Number of Deaths due to Diphtheria Averted by Vaccines (in Thousand), 2001
Table 8-2: Global - Cumulative Confirmed Human Cases & Number of Deaths due to Avian Influenza A/ (H5N1), 2003-2007
Table 9-1: Global - Share of Vaccines in Total Pharma Sales of Major Players (%), 2005
Table 9-2: Global - Growth of Vaccines Segment of Major Pharma Players (%), 2005
Table 9-3: Global - Overall Growth of Major Pharma Players (%), 2005
Table 9-4: Global - Major Vaccine Companies (Segmentation by Revenue)
Table 9-5: Sanofi-Aventis - Key Financials (in Million US$), 2004-2006
Table 9-6: GlaxoSmithKline Plc. - Key Financials (in Million US$), 2004-2006
Table 9-7: Merck & Co., Inc. - Key Financials (in Million US$), 2004-2006
Table 9-8: Novartis - Key Financials (in Million US$), 2004-2006
Table 9-9: Wyeth - Key Financials (in Million US$), 2004-2006
